Newsletter December 2020

2020 has been a difficult year for everyone. However, despite the many…

Words Lucie van Leeuwen.Published January 5, 2021
Newsletter December 2020

2020 has been a difficult year for everyone. However, despite the many challenges, we can also look back on some milestone achievements. In our latest newsletter, we review some of our major highlights. Click the link to read our newsletter: http://bit.ly/3njT6nQ

Would you like to receive our next newsletter in your email? You can subscribe here: https://www.tricals.org/subscribe-to-our-newsletter/

We look forward to the new year in which we will undoubtedly achieve even more together. Together we will build our highway towards new therapies for ALS.


Share

Related news

Amylyx Pharmaceuticals and TRICALS to collaborate on phase 3 clinical trial
Amylyx Pharmaceuticals and TRICALS to collaborate on phase 3 clinical trial
Today, Amylyx Pharmaceuticals provided an update on its plans to advance its […]
Retrotope announces initiation of RT001 study in people with ALS
Retrotope announces initiation of RT001 study in people with ALS
Retrotope Inc has announced that the first participants have been enrolled in […]
Virtual ENCALS meeting 2021
Virtual ENCALS meeting 2021
This year, ENCALS (European Network to Cure ALS) will be organising their […]
New centres in Portugal and Spain join TRICALS network
New centres in Portugal and Spain join TRICALS network
We are very excited to announce that recently two new expert ALS […]